Institutional investors purchased a net $4.0 million shares of ENZ during the quarter ended April 2014. This may signal that the smart money is gaining interest in this company as the 42.22% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.1 Million shares of Enzo Biochem Inc
KOPP INVESTMENT ADVISORS LLC Bought 472.3 Thousand shares of Enzo Biochem Inc
COLUMBIA PARTNERS LLC INVESTMENT... Bought 426.1 Thousand shares of Enzo Biochem Inc